GUALANDI, Francesca
 Distribuzione geografica
Continente #
NA - Nord America 12.549
AS - Asia 6.096
EU - Europa 4.128
SA - Sud America 1.067
AF - Africa 163
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 4
AN - Antartide 1
Totale 24.021
Nazione #
US - Stati Uniti d'America 12.269
SG - Singapore 2.412
CN - Cina 1.438
BR - Brasile 852
DE - Germania 845
VN - Vietnam 760
PL - Polonia 644
IT - Italia 607
UA - Ucraina 428
GB - Regno Unito 419
HK - Hong Kong 415
FI - Finlandia 291
TR - Turchia 285
SE - Svezia 188
RU - Federazione Russa 167
FR - Francia 164
IN - India 154
CA - Canada 142
JP - Giappone 139
BD - Bangladesh 135
MX - Messico 96
AR - Argentina 87
ID - Indonesia 81
NL - Olanda 71
ZA - Sudafrica 65
BE - Belgio 59
ES - Italia 54
IQ - Iraq 49
CO - Colombia 35
PK - Pakistan 34
CZ - Repubblica Ceca 32
LT - Lituania 32
AT - Austria 28
VE - Venezuela 28
EC - Ecuador 27
MA - Marocco 24
UZ - Uzbekistan 23
SA - Arabia Saudita 22
PH - Filippine 20
LK - Sri Lanka 19
TN - Tunisia 17
IE - Irlanda 15
JO - Giordania 13
KE - Kenya 13
MY - Malesia 13
RO - Romania 13
AE - Emirati Arabi Uniti 12
DZ - Algeria 12
CL - Cile 11
EG - Egitto 11
JM - Giamaica 11
PY - Paraguay 11
CH - Svizzera 10
AU - Australia 9
IR - Iran 9
NP - Nepal 9
BY - Bielorussia 8
OM - Oman 8
IL - Israele 7
CR - Costa Rica 6
HU - Ungheria 6
PA - Panama 6
RS - Serbia 6
UY - Uruguay 6
AZ - Azerbaigian 5
HR - Croazia 5
PE - Perù 5
BO - Bolivia 4
DO - Repubblica Dominicana 4
KG - Kirghizistan 4
LV - Lettonia 4
MK - Macedonia 4
QA - Qatar 4
XK - ???statistics.table.value.countryCode.XK??? 4
AL - Albania 3
BB - Barbados 3
BG - Bulgaria 3
CY - Cipro 3
DK - Danimarca 3
GR - Grecia 3
KR - Corea 3
KZ - Kazakistan 3
LB - Libano 3
MD - Moldavia 3
NG - Nigeria 3
NI - Nicaragua 3
NZ - Nuova Zelanda 3
PS - Palestinian Territory 3
SI - Slovenia 3
SN - Senegal 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
ET - Etiopia 2
GT - Guatemala 2
HN - Honduras 2
KH - Cambogia 2
ME - Montenegro 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
Totale 23.993
Città #
Ashburn 1.594
Singapore 1.475
Fairfield 1.107
San Jose 900
Woodbridge 868
Chandler 661
Warsaw 635
Houston 621
Beijing 560
Ann Arbor 549
Jacksonville 443
Santa Clara 439
Seattle 434
Hong Kong 408
Munich 363
Wilmington 359
Cambridge 351
Los Angeles 288
New York 273
Ho Chi Minh City 261
Dallas 200
Hanoi 165
Izmir 142
Tokyo 136
Helsinki 120
Princeton 118
Nanjing 111
Ferrara 107
Lauterbourg 100
Milan 97
Shanghai 92
San Diego 90
São Paulo 89
Boardman 82
Council Bluffs 82
Orem 82
Turku 82
Buffalo 81
London 81
Bremen 77
Brooklyn 56
Jakarta 56
Chicago 53
Mexico City 53
Montreal 53
Johannesburg 50
Brussels 48
Dearborn 45
Chennai 44
Shenyang 44
Frankfurt am Main 43
Denver 42
Hefei 41
Da Nang 39
Nanchang 39
Atlanta 38
Stockholm 36
Toronto 36
Falls Church 35
Tianjin 35
Poplar 34
Bologna 33
Falkenstein 33
Phoenix 33
The Dalles 29
Changsha 28
San Mateo 28
San Francisco 27
Hebei 26
Boston 24
Rio de Janeiro 24
Amsterdam 23
Haiphong 23
Nuremberg 23
Redwood City 23
Rome 22
Tashkent 22
Brasília 21
Jiaxing 21
Brno 20
Ankara 19
Belo Horizonte 19
Jinan 19
Washington 19
Baghdad 18
Mumbai 18
Norwalk 18
Kunming 17
Moscow 17
Ottawa 17
Hải Dương 16
Manchester 16
Curitiba 15
Verona 15
Columbus 14
Leawood 14
Philadelphia 14
Auburn Hills 13
Nairobi 13
Charlotte 12
Totale 16.449
Nome #
Deep RNA profiling identified CLOCK and molecular clock genes as pathophysiological signatures in collagen VI myopathy 472
POPDC1S201F causes muscular dystrophy and arrhythmia by affecting protein trafficking 429
Transcriptional and epigenetic analyses of the DMD locus reveal novel cis-acting DNA elements that govern muscle dystrophin expression 411
Persistent Dystrophin Protein Restoration 90 Days after a Course of Intraperitoneally Administered Naked 2′OMePS AON and ZM2 NP-AON Complexes in mdx Mice 310
A novel mutation of BEST1 gene in Best disease 309
Omics approach and novel biostatistic tools identified RPL3L as potential genetic modifier of clinical severity in female carriers of Duchenne muscle dystrophy 282
Cationic PMMA nanoparticles bind and deliver antisense oligoribonucleotides allowing restoration of dystrophin expression in the mdx mouse 281
A Family with γ-Thalassemia and High Hb A2 Levels 274
Genetic characterization in symptomatic female DMD carriers: lack of relationship between X-inactivation, transcriptional DMD allele balancing and phenotype 272
Paternal germline mosaicism in collagen VI related myopathies 272
Macrophages: a minimally invasive tool for monitoring collagen VI myopathies 272
Antisense-Induced Messenger Depletion Corrects a COL6A2 Dominant Mutation in Ullrich Myopathy 269
Transcriptomics analysis in collagen VI myopathy: Role of circadian genes using novel fluidic card tools 267
A novel custom high density-comparative genomic hybridization array detects common rearrangements as well as deep intronic mutations in dystrophinopathies 264
Genetic counseling for women referred for advanced maternal age: a telegenetic approach 264
G.P.12.06 A comprehensive molecular characterisation of dystrophinopathies 260
A Clinical Case of Catecholaminergic Polymorphic Ventricular Tachycardia: The Clinical Suspicious and the Need of Genetics 255
A comprehensive genomic approach for neuromuscular diseases gives a high diagnostic yield 254
Characterization of a rare case of Ullrich congenital muscular dystrophy due to truncating mutations within the COL6A1 gene C-terminal domain: a case report 252
Identification of a deep intronic mutation in the COL6A2 gene by a novel custom oligonucleotide CGH array designed to explore allelic and genetic heterogeneity in collagen VI-related myopathies 251
GENETIC, CLINICAL AND NEUROPATHOLOGICAL INSIGHTS INTO PATIENTS WITH ASCERTAINED DIAGNOSIS OF HUNTINGTON DISEASE 248
Audiological profiles and gjb2, gjb6 mutations: A retrospective study on genetic and clinical data from 2003 to 2008 247
Intronic breakpoint definition and transcription analysis in DMD/BMD patients with deletion/duplication at the 5′ mutation hot spot of the dystrophin gene 245
Autosomal recessive Bethlem myopathy 244
Autosomal recessive myosclerosis myopathy is a collagen VI disorder 242
Exon skipping-mediated dystrophin reading frame restoration for small mutations 241
Mitochondrial dysfunction in the pathogenesis of Ullrich congenital muscular dystrophy and prospective therapy with cyclosporins 234
A novel KCNA1 mutation in a patient with paroxysmal ataxia, myokymia, painful contractures and metabolic dysfunctions 233
Antisense modulation of both exonic and intronic splicing motifs induces skipping of a DMD pseudo-exon responsible for X-linked dilated cardiomyopathy 232
Mutation Load of Multiple Ion Channel Gene Mutations in Brugada Syndrome 230
Attualità e nuove prospettive in tema di cardiogenetica 230
International-DMD (IDMD): a PTC Therapeutics-supported diagnostic project to widely identify Dystrophin mutations by NGS technologies 229
Occurrence of Del(GIB6-D13S1830) mutation in Italian non-syndromic hearing loss patients carrying a single GJB2 mutated allele 228
Mole maker phenotype: possible narrowing of the candidate region. 228
Melanocytes--a novel tool to study mitochondrial dysfunction in Duchenne muscular dystrophy 227
A patient with limb girdle muscular dystrophy carries a TRIM32 deletion, detected by a novel CGH array, in compound heterozygosis with a nonsense mutation 225
The absence of dystrophin brain isoform expression in healthy human heart ventricles explains the pathogenesis of 5 ' X-linked dilated cardiomyopathy 224
6 minute walk test in Duchenne MD patients with different mutations: 12 month changes 222
Defective collagen VI α6 chain expression in the skeletal muscle of patients with collagen VI-related myopathies. 222
Mutation analysis of the MECP2 gene in British and Italian Rett syndrome females 218
Homozygous Recessive Versican Missense Variation Is Associated With Early Teeth Loss in a Pakistani Family 214
Attention Deficit Hyperactivity Disorder and Cognitive Function in Duchenne Muscular Dystrophy: Phenotype-Genotype Correlation 214
Commercial kit-based diagnosis is not enough for prenatal testing of beta-thalassemia: pitfalls in diagnostic mutation analysis raises the need for reference laboratories 214
The medical genetics of dystrophinopathies: Molecular genetic diagnosis and its impact on clinical practice 211
Exploring the clinical and epidemiological complexity of GJB2-linked deafness 209
Rapid, comprehensive analysis of the dystrophin transcript by a custom micro-fluidic exome array 209
The DMD Locus Harbours Multiple Long Non-Coding RNAs Which Orchestrate and Control Transcription of Muscle Dystrophin mRNA Isoforms 208
LAMM syndrome with Middle Ear Dysplasia associated with compound heterozygosity for FGF3 mutations. 208
Custom CGH array profiling of copy number variations (CNVs) on chromosome 6p21.32 (HLA locus) in patients with venous malformations associated with multiple sclerosis 207
Transcriptional behavior of DMD gene duplications in DMD/BMD males 207
Ethnicity-related DMD Genotype Landscapes in European and Non-European Countries 205
Nonhomologous Robertsonian translocations (NHRTs) and uniparental disomy (UPD) risk: An Italian multicentric prenatal survey 204
Characterization of a 4-Mb region at chromosome 6q21 harboring a replicative senescence gene 204
MECP2 gene mutation analysis in the British and Italian Rett Syndrome patients: hot spot map of the most recurrent mutations and bioinformatic analysis of a new MECP2 conserved region 202
Identification and characterization of novel collagen VI non-canonical splicing mutations causing ullrich congenital muscular dystrophy 202
Dystrophin levels as low as 30% are sufficient to avoid muscular dystrophy in the human 201
A novel KCNA1 mutation identified in an Italian family affected by episodic ataxia type 1 195
SERCA1 protein expression in muscle of patients with Brody disease and Brody syndrome and in cultured human muscle fibers. 194
Huntington's disease-like presentation in Spinocerebellar ataxia type 12 194
T.P.2.07 The systemic administration of a low dose of 2OMePS-AON combined with novel cationic polymethylmethacrylate nanoparticles induces the rescue of dystrophin expression in the mdx murine model 194
A CMT2 family carrying the P7R mutation in the N- terminal region of the HSPB1 gene 192
Becker muscular dystrophy due to an intronic splicing mutation inducing a dual dystrophin transcript 192
Prevalence of congenital muscular dystrophy in Italy: a population study 190
RNA-seq in DMD urinary stem cells recognized muscle-related transcription signatures and addressed the identification of atypical mutations by whole-genome sequencing 188
An interconnected data infrastructure to support large-scale rare disease research 187
Physical and transcriptional characterization of human urinary stem cell populations 187
Functional characterization of two novel mutations in scn5a associated with brugada syndrome identified in Italian patients 187
DMD gene molecular genetic characterization in Eastern Europe and non European countries 184
RNAseq in urine-derived stem cells identified the expression of 308 neuromuscular gene transcripts [NEXT GENERATION SEQUENCING AND EXPERIMENTAL MYOLOGY: P.384] 181
Systemic Expression of HIV-1 tat Gene in Transgenic Mice Induces Endothelial Proliferation and Ibmors of Different Histotypes 180
Genomic definition of a pure intronic dystrophin deletion responsible for an XLDC splicing mutation: In vitro mimicking and antisense modulation of the splicing abnormality 177
The Genetic Landscape of Dystrophin Mutations in Italy: A Nationwide Study 175
Predictors of cardiac arrhythmic events in non coronary artery disease patients 173
In vivo study of an aberrant dystrophin exon inclusion in X-linked dilated cardiomyopathy 172
Un anno di attività diagnostica del laboratorio di Genetica molecolare di Ferrara 171
Report of a novel ATP7A mutation causing distal motor neuropathy 169
Patterns of late gadolinium enhancement in Duchenne muscular dystrophy carriers 168
NMD CHIP: Un Progetto Europeo per la diagnosi delle patologie neuromuscolari 168
A recurrent COL6A1 pseudoexon insertion causes muscular dystrophy and is effectively targeted by splice-correction therapies 167
Left ventricular myocardial noncompaction with advanced atrioventricular conduction disorder and ventricular arrhythmias in a young patient: Role of MIB1 gene 167
Digital health and Clinical Patient Management System (CPMS) platform utility for data sharing of neuromuscular patients: the Italian EURO-NMD experience 164
Investigating the mechanism of chromosomal deletion: Characterization of 39 deletion breakpoints in introns 47 and 48 of the human dystrophin gene 164
Lamin A/C Missense Mutation R216C Pinpoints Overlapping Features Between Brugada Syndrome and Laminopathies 164
Calpain 3 deficiency presenting as fibre type disproportion: Scientific correspondence 161
Progress in understanding GJB2-linked deafness 160
Uso di modelli di trasformazione virale nello studio dei geni oncosoppressori tramite trasferimento monocromosomico. 159
Prenatal diagnosis of Duchenne muscular dystrophy by comparative genomic hybridization 159
Clinical, morphological and genetic studies in a cohort of 21 patients with myofibrillar myopathy 159
Paroxysmal non-kinesigenic dyskinesia is caused by mutations of the MR-1 mitochondrial targeting sequence. 157
Somatic mosaicism represents an underestimated event underlying collagen 6-related disorders 156
Early neurodevelopmental assessment in Duchenne muscular dystrophy 154
Localizzazione preliminare di tumor suppressor genes mediante chromosome transfer. 149
Tumorigenicity and anchorage-independent growth suppression of BK virus transformed mouse cells by human chromosome 11 148
Intrapericardial rupture of aortic aneurysm in anatomic aortic arch variant: a multidisciplinary approach 148
Duchenne muscular dystrophy and epilepsy 147
G.P.3.02 In vivo biodistribution of non-viral systems for oligoribonucleotides delivery 146
Type 1 Brugada Pattern Is Associated With Echocardiography-Detected Delayed Right Ventricular Outflow Tract Contraction 144
ncRNAs originating from the dystrophin gene as biomarker for assessing antisense therapy 142
Nanoparticle-Mediated Delivery of Antisense Oligoribonucleotides Allows Restoration of Dystrophin Expression in the mdx Mouse 141
Genetic analysis of a 6q21 region harboring a senescence gene: construction of a 4 megabase yeast artificial chromosome contig 141
Totale 21.303
Categoria #
all - tutte 104.315
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 643
Totale 104.958


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202194 0 0 0 0 0 0 0 0 0 0 0 94
2021/20221.393 66 96 112 51 79 55 112 66 55 91 148 462
2022/20231.477 131 153 31 186 295 171 66 135 171 15 82 41
2023/2024860 71 98 65 12 67 196 25 57 10 20 19 220
2024/20253.774 69 65 258 181 430 314 253 194 696 379 514 421
2025/20269.345 1.008 357 766 1.175 1.476 631 1.237 521 766 931 438 39
Totale 24.243